Company Overview and News

Maxim (MXIM) Offers Design Efficiency With Digital Amplifiers

2018-05-16 zacks
Reportedly Maxim Integrated Products, Inc.’s (MXIM - Free Report) digital audio amplifiers are gaining traction, courtesy of their audio quality enhancing ability. MAX98357 and MAX98358 provide 3.2W of Class AB audio performance with Class D efficiency in audio quality. With these amplifiers, designers are now being able to reduce their solution size which was difficult with analog amplifiers as they would affect the overall size of the solution.

Why NXP Semiconductors (NXPI) Could Be Positioned for a Slump

2018-05-15 zacks
Similar to wise buying decisions, exiting certain underperformers at the right time helps maximize portfolio returns. Selling off losers can be difficult, but if both the share price and estimates are falling, it could be time to get rid of the security before more losses hit your portfolio. One such stock that you may want to consider dropping is NXP Semiconductors N.V. (NXPI - Free Report) , which has witnessed a significant price decline in the past four weeks, and it has seen negative earnings estimate revisions for the current quarter and the current year.

NXP Semiconductors (NXPI) Catches Eye: Stock Jumps 8.6%

2018-05-07 zacks
NXP Semiconductors N.V. (NXPI - Free Report) was a big mover last session, as the company saw its shares rise nearly 9% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This reverses the recent trend for the company—as the stock is now down 11.8% in the past one-month time frame.

Silicon Laboratories (SLAB) Q1 2018 Results - Earnings Call Transcript

2018-04-25 seekingalpha
Good morning. My name is Marcella and I will be your conference operator today. At this time, I'd like to welcome everyone to the Silicon Labs First Quarter Fiscal 2018 Earnings Conference Call. All lines have been placed on mute to prevent any background noise. After the speakers' remarks there will be a question-and-answer session.

Silicon Laboratories, Inc. 2018 Q2 - Results - Earnings Call Slides

2018-04-25 seekingalpha
The following slide deck was published by Silicon Laboratories, Inc. in conjunction with their 2018 Q2 earnings call.

Semi Stocks Reporting Earnings This Week: AMD, CAVM & More

2018-04-24 zacks
The Q1 earnings cycle is in full swing, with a number of semiconductor companies slated to report their quarterly numbers over the next few days. The industry serves as a driver, enabler and indicator of technological progress. According to the Earnings Preview dated Apr 20, technology, along with the finance sector, will bring in more than 40% of the S&P 500 index’s total earnings this year. Per the report, Q1 total earnings for the tech sector are projected to be up 20.

Sigma Designs, Inc. Reports Fourth Quarter and Fiscal Year 2018 Financial Results

2018-04-20 globenewswire
FREMONT, Calif., April 20, 2018 (GLOBE NEWSWIRE) -- Sigma Designs, Inc.® (NASDAQ:SIGM), a developer of technology for use in the mobile Internet of Things (IoT) market, today reported financial results for its fourth quarter and fiscal year 2018, which ended February 3, 2018. Due to the previously announced asset sale to Silicon Labs (NASDAQ:SLAB) the Company will not hold an earnings conference call.

SLAB / Silicon Laboratories, Inc. DEF 14A


SLAB / Silicon Laboratories, Inc. DEFA14A


Attractive Return From Sigma Liquidation

2018-02-21 seekingalpha
Sigma Designs, Inc. (SIGM) builds domain-specific system-on-chip solutions for home connectivity. Sigma's recent merger agreement with Silicon Laboratories (SLAB) fell through, and now, SIGM is dismantling itself, selling what divisions can be sold and shuttering the rest. The company will then distribute proceeds to shareholders and liquidate. As the current share price is meaningfully below reasonable estimates of liquidation value, an investment in SIGM provides a compelling risk-reward ratio.

SLAB / Silicon Laboratories, Inc. / VANGUARD GROUP INC - 3G/A (Passive Investment)

siliconlaboratoriesinc.htm - Generated by SEC Publisher for SEC Filing SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   Schedule 13G   Under the Securities Exchange Act of 1934 (Amendment No.: 5 )*       Name of issuer:  Silicon Laboratories Inc     Title of Class of Securities:  Common Stock     CUSIP Number:  826919102     Date of Event Which Requires Filing of this Statement: December 31, 2017   Check the appropriate box to designate the rule pursuant to which this Schedule is file

Related Articles

ANTH: Anthera Pharmaceuticals Analysis and Research Report

2018-05-21 - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

AGEN: Agenus Inc Analysis and Research Report

2018-05-21 - Asif

Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...

SQ: Square Analysis and Research Report

2018-05-21 - Asif

Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...

CUSIP: 826919102